This page lists all pharmaceutical reports related to the field of Metabolic & Hormonal Disorders. The reports include market research reports and pipeline analyses.
Displaying 151 - 180 of 180 results
- The Global OTC Pharmaceutical Market 2009-2024
- In Vitro Diagnostics Market Analysis 2009-2024
- The Diabetes Market Outlook To 2014: Market dynamics, competitive landscape, emerging therapies
- World Diabetes Market Analysis, 2009-2023
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
- Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
- Rx to OTC Switches 2009
- Obesity, Weight Loss and Diet Management Markets (Pharmaceutical, Surgical and Dietary Approaches)
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- Pipeline Insight: Endometriosis - New therapies near market while more innovative targets still needed
- Forecast Insight: Dyslipidemia - While the market collapses, a well designed clinical trial program pays dividends for Crestor
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- Commercial Insight: Cardiovascular and metabolic market overview
- Pipeline and Commercial Insight: Obesity - the $11 billion market that never was
- Stakeholder Opinions: Ophthalmology - Leading brands under threat
- Osteoporosis - Drug Pipeline Analysis and Market Forecasts to 2016
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- The Future of Metabolic Disorder Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- The Future of the Home Healthcare Equipment Market to 2016 - Market Forecasts, Competitive Landscape and Pipeline Analysis
- World Ophthalmic Pharmaceutical Market 2010-2025
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
- Pricing and Reimbursement Strategies for Diagnostics: Overcoming reimbursement issues and navigating the regulatory environment